Trials / Conditions / Advanced Unresectable Solid Tumors
Advanced Unresectable Solid Tumors
3 registered clinical trials studyying Advanced Unresectable Solid Tumors.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresec NCT04894825 | FutureGen Biopharmaceutical (Beijing) Co., Ltd | Phase 1 |
| Terminated | Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid NCT02508441 | Andes Biotechnologies | Phase 1 |
| Completed | A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors NCT02428712 | Fore Biotherapeutics | Phase 1 / Phase 2 |